These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36226174)

  • 1. Comprehensive analysis of somatic mutator-derived and immune infiltrates related lncRNA signatures of genome instability reveals potential prognostic biomarkers involved in non-small cell lung cancer.
    Yang CZ; Yang T; Liu XT; He CF; Guo W; Liu S; Yao XH; Xiao X; Zeng WR; Lin LZ; Huang ZY
    Front Genet; 2022; 13():982030. PubMed ID: 36226174
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel GIRlncRNA Signature for Predicting the Clinical Outcome and Therapeutic Response in NSCLC.
    Zhang Q; Liu X; Chen Z; Zhang S
    Front Pharmacol; 2022; 13():937531. PubMed ID: 35991889
    [No Abstract]   [Full Text] [Related]  

  • 3. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
    Jiao Y; Li S; Wang X; Yi M; Wei H; Rong S; Zheng K; Zhang L
    Front Immunol; 2022; 13():929846. PubMed ID: 35990656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.
    Jin C; Zhao JS; Huang XQ; Yang XZ; Niu FY; Lin JR; Ma L; Shi YX; Li XS; Jiang P; Gao S; Li F; Song Y
    Hepatol Int; 2022 Oct; 16(5):1220-1233. PubMed ID: 35947245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
    Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G
    Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma.
    Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Wang X
    Front Genet; 2021; 12():720013. PubMed ID: 34777461
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma.
    Fang X; Liu X; Lu L; Liu G
    Front Oncol; 2021; 11():728181. PubMed ID: 34676164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment.
    Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N
    Front Genet; 2021; 12():706661. PubMed ID: 34712264
    [No Abstract]   [Full Text] [Related]  

  • 10. Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma.
    Zhu J; Huang Q; Liu S; Peng X; Xue J; Feng T; Huang W; Chen Z; Lai K; Ji Y; Wang M; Yuan R
    Front Immunol; 2022; 13():856186. PubMed ID: 35479067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Genomic Instability of m
    Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ
    Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906
    [No Abstract]   [Full Text] [Related]  

  • 12. Systematic analysis of ferroptosis-related long non-coding RNA predicting prognosis in patients with lung squamous cell carcinoma.
    Yao N; Zuo L; Yan X; Qian J; Sun J; Xu H; Zheng F; Efird JT; Kawagoe I; Wang Y; Ni S
    Transl Lung Cancer Res; 2022 Apr; 11(4):632-646. PubMed ID: 35529787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploring the Prognostic Significance and Immunotherapeutic Potential of Single-Cell Sequencing-Identified Long Noncoding RNA (LncRNA) in Patients With Non-small Cell Lung Cancer.
    Chen L; Wang L; Xiong Z; Zhu X; Chen L
    Cureus; 2023 Nov; 15(11):e48436. PubMed ID: 38074028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis.
    Wu J; Ren X; Wang N; Zhou R; Chen M; Cai Y; Lin S; Zhang H; Xie X; Dang C; Zhang S; Zhou Z
    Front Genet; 2021; 12():779554. PubMed ID: 34880908
    [No Abstract]   [Full Text] [Related]  

  • 17. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel cellular senescence-related lncRNA signature for prognosis and immune response in osteosarcoma.
    Wu H; Deng C; Zheng X; Huang Y; Chen C; Gu H
    Transl Cancer Res; 2024 Jul; 13(7):3742-3759. PubMed ID: 39145087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature.
    Jing L; Du Y; Fu D
    Front Genet; 2022; 13():979575. PubMed ID: 36105083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.